Contact: Johan Bostedt
C-RAD was founded in 2004. The founders are researchers from Karolinska Institutet and the Royal Institute of Technology in Stockholm, clinics at Karolinska Hospital in Solna and people with extensive industrial experience in the field of radiation therapy.
C-RAD develops innovative solutions for use in advanced radiation therapy. The C-RAD group offers products and solutions for patient positioning, tumor localization and radiation treatment systems.
The first product was launched in 2006, when C-RAD introduced the Sentinel system, which was based on laser scanning technology and the c4D software platform. The technology has constantly evolved since the first deliveries were made in 2007.
In 2011, C-RAD launched the Catalyst system, a next-generation optical surface scanning system. The most recent product, Catalyst HD was released in December 2013, focusing advanced stereotactic radiation therapy. As the booming market for Proton treatment, C-RAD released Catalyst PT to support the Proton treatment too.
On Jul. 20, 2015, C-RAD has acquired the Franco-Belgian Cyrpa group. Cyrpa develops innovative laser solutions for patient positioning and virtual simulation within radiation therapy.